Bora Pharmaceuticals Co., LTD.

TWSE:6472 주식 보고서

시가총액: NT$82.3b

Bora Pharmaceuticals 대차 대조표 상태

재무 상태 기준 확인 3/6

Bora Pharmaceuticals 의 총 주주 지분은 NT$13.9B 이고 총 부채는 NT$17.9B, 이는 부채 대 자기자본 비율을 128.3% 로 가져옵니다. 총자산과 총부채는 각각 NT$43.6B 및 NT$29.6B 입니다. Bora Pharmaceuticals 의 EBIT는 NT$4.0B 이며 이자보상배율은 13.1 입니다. NT$6.5B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

128.3%

부채 비율

NT$17.87b

부채

이자 보상 비율13.1x
현금NT$6.48b
주식NT$13.93b
총 부채NT$29.64b
총 자산NT$43.57b

최근 재무 상태 업데이트

Recent updates

Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem

Nov 21
Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem

Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?

Oct 04
Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?

Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Jul 18
Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Jun 13
Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Apr 08
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Mar 14
Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Apr 30
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Mar 17
Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

Feb 17
Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Jan 27
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

Jan 19
Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Dec 29
We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Dec 09
Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

재무 상태 분석

단기부채: 6472 의 단기 자산 ( NT$23.8B )이 단기 부채( NT$13.1B ).

장기 부채: 6472 의 단기 자산( NT$23.8B )이 장기 부채( NT$16.5B ).


부채 대 자본 내역 및 분석

부채 수준: 6472 의 순부채 대 자기자본 비율( 81.7% )은 높음으로 간주됩니다.

부채 감소: 6472 의 부채 대 자기자본 비율은 지난 5년간 32% 에서 128.3% 로 증가했습니다.

부채 범위: 6472 의 부채는 영업 현금 흐름 ( 13.2% )에 의해 잘 갚지 않음입니다.

이자 보장: 6472 의 부채에 대한 이자 지급EBIT( 13.1 x 적용 범위)로 잘 충당됩니다.


대차 대조표


건강한 기업 발견하기